nerolidol has been researched along with Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, AM; Barreto, AS; de S S Barreto, R; Gonçalves, MSS; Heimfarth, L; Quintans Júnior, LJ; Santana, IR; Santos, DM; Santos, MRV; Santos, VCO; Silva, EAP; Souza, DS; Vasconcelos, CML | 1 |
1 other study(ies) available for nerolidol and Myocardial Infarction
| Article | Year |
|---|---|
Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Isoproterenol; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Wistar; Sesquiterpenes; Superoxide Dismutase | 2022 |